Turkey's Medicana Health Group invests EUR 10 million in Elekta cancer treatment equipment

ANKARA, Turkey, May 11, 2016 – Elekta (EKTA-B.ST) announced today that Medicana Health Group, one of Turkey's largest private health care networks, invests more than EUR 10 million to purchase sophisticated equipment and software to treat cancer.

The deal includes Elekta’s Versa HD™ and Synergy Platform linear accelerators as well as MOSAIQ® oncology information systems and Monaco® treatment planning systems.

Salih Bilgin, Elekta’s General Manager for Business Unit Turkey, says: “Medicana is a growing hospital network, with increased focus on cancer care. We are very happy to be able to support them in their ambition to offer the highest quality health care services in Turkey. Their choice of Elekta and our sophisticated Versa HD linear accelerators together with Monaco treatment planning systems, will provide their clinicians with unprecedented accuracy and speed.”

Hüseyin Bozkurt, Medicana’s Chairman, says the company desires to grow with an increasing focus on cancer treatment. ‘’We plan to open five new hospitals in the coming three years and to increase our presence in the radiation therapy segment with top of the line, latest technology linear accelerators, and fully integrated oncology information systems. We will continue to provide the latest developments in cancer treatment and the highest quality health services in all our hospitals.”

Elekta’s sophisticated cancer treatment equipment will initially be installed in hospitals in Ankara, Bursa, İzmir and Istanbul. The order was booked in the fourth quarter of Elekta’s fiscal year (2015-16) and the first delveries are expected in May, 2016.

# # #

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on May 11, 2016.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.About Medicana Healthcare Group’s Cancer Treatment UnitsMedicana Healthcare Group satisfies a significantly huge need of cancer care in İstanbul and Anatolia with its advanced cancer treatment centers at hospitals in Ankara, İstanbul, Konya, Samsun and Sivas.Some of our centers offer cutting-edge cancer treatment using multislice Computed Tomography (MSCT), PET-CT, magnetic resonance, ultrasonography, linear accelerator devices which can perform IMRT, conventional radiology and nuclear medicine imaging methods or radiation oncology and nuclear medicine units, which are present in private sector hospital for the first time.By closely following modern and sophisticated medical technologies, Medicana Healthcare Group continuously updates its high-end device substructure. The company offers patients the best diagnosis and treatment opportunities available.

Press Releases


PDF Version

For further information, please contact

Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242,
E-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017,
E-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time